Gas Exchange Pulmonary Function Testing Market Trends
The market is witnessing notable trends driven by the increasing prevalence of respiratory diseases and advancements in technology.
A key trend is the shift towards portable pulmonary function testing (PFT) systems, which offer greater flexibility and ease of use in various settings, including independent clinics and home care environments. This transition is fueled by technological innovations that enhance the capabilities of these devices, enabling them to measure multiple parameters effectively.
Additionally, the rising awareness of chronic respiratory conditions, such as asthma and chronic obstructive pulmonary disease (COPD), is driving demand for accurate diagnostic tools that facilitate early detection and ongoing monitoring.
The market is also benefiting from increased product launches and a focus on point-of-care testing solutions, which allow for immediate results and improved patient management. As healthcare providers prioritize efficient and reliable pulmonary function tests, the market is set to experience sustained growth, particularly in regions with a rising burden of respiratory illnesses.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
The global gas exchange pulmonary function testing industry was valued at USD 238.5 million in 2023 and is expected to grow at a CAGR of 5.8% from 2024 to 2032, driven by the increasing prevalence of respiratory diseases.
The portable segment is projected to expand at a CAGR of 6%, reaching over USD 329 million by 2032, fueled by the rising demand for point-of-care testing.
North America market accounted for USD 96.5 million in 2023 and is anticipated to grow at a CAGR of 5.2% between 2024 and 2032, driven by the increasing incidence of lung cancer.
Key players in the industry include CHEST, COSMED, ECO MEDICS, Geratherm Medical, KoKo PFT, Koninklijke Philips, and MGC Diagnostics Corporation.
Gas Exchange Pulmonary Function Testing Market Scope